1 results match your criteria: "Tenon and Saint-Louis Hospitals[Affiliation]"
High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocol.
Eur J Cancer
January 2005
Tenon and Saint-Louis Hospitals, Assistance Publique-Hôpitaux de Paris, 3 avenue Victoria, 75003 Paris, France.
Article Synopsis
- - Our study evaluated the effectiveness of high-dose chemotherapy (HD-CT) compared to conventional chemotherapy (CT) for patients with metastatic breast cancer, involving 61 patients from 1992 to 1996.
- - Results showed that patients receiving HD-CT had a median time to progression (TTP) of 12 months, significantly better than the 6 months for the standard CT group, with lower relapse rates at both 2 and 5 years.
- - The median overall survival (OS) was also longer for HD-CT patients, with 44.1 months compared to 19.3 months for standard CT, suggesting HD-CT may improve patient outcomes, but more research is required to confirm its long